Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02913014 · ClinicalTrials.gov registry record · NA
Comparison of Recurrence of Atrial Fibrillation Post Cryoballon Ablation During the 90-day Blanking Period-with and Without Anti-arrhythmic Drug Therapy
A NA study, sponsored by Prisma Health-Midlands.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02913014 is a NA study that has completed, run by Prisma Health-Midlands. The registered enrollment target is 50 participants.
The verdict
NCT02913014, a NA study, has completed, sponsored by Prisma Health-Midlands.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study is being done to find out if patients taking Anti Arrhythmia Drugs (AADs) after cryoballoon ablation for atrial fibrillation, compared to patients who do not take Anti- Arrhythmic Drugs after an ablation affect Atrial Fibrillation from coming back. The study will also look at the side effects of the AADs.
Interventions
- OTHER No AAD post Ablation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-06-28 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02913014
The ClinicalTrials.gov registry entry for NCT02913014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prisma Health-Midlands, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No AAD post Ablation. is the first listed.
NCT02913014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02913014 about?
NCT02913014 is a clinical study titled "Comparison of Recurrence of Atrial Fibrillation Post Cryoballon Ablation During the 90-day Blanking Period-with and Without Anti-arrhythmic Drug Therapy". This study is being done to find out if patients taking Anti Arrhythmia Drugs (AADs) after cryoballoon ablation for atrial fibrillation, compared to patients who do not take Anti- Arrhythmic Drugs after an ablation affect Atrial Fibrillation from coming back. The study will also look at the side eff...
What is the current status of trial NCT02913014?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-06-28. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT02913014?
The interventions under investigation include: No AAD post Ablation. (OTHER).
Who is sponsoring clinical trial NCT02913014?
This trial is sponsored by Prisma Health-Midlands, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.